Multiple sclerosis (MS) is the most common human demyelinating disease of the CNS. The etiology of MS is poorly understood, however, it is widely believed as a T cell-mediated autoimmune disease that ultimately targets the CNS Multiple Sclerosis and Experimental Allergic Encephalomyelitis Pahan K. Results of key natural history of studies from carefully managed data sets have unfortunately lead some leading experts in the field of multiple sclerosis to conclude that the most severe cases of multiple sclerosis are causally connected to degenerative processes as the primary driver of disability. A strong relationship between age and disability bolsters this thinking. The epidemiologic facts derived from these and other important studies are sometimes combined with the shortcomings of treatment trials to formulate legitimate questions concerning the long-term impact of our therapies, which are felt to principally impact relapses and inflammation mediated injury (having unknown effects on long term degeneration) The Clinical Course of Multiple Sclerosis Needs to be Redefined in the Treatment Era of MS Scott TF.
This international journal of multiple sclerosis is an academic journal dealing with the clinical cases based on multiple sclerosis as well as the experimental and research highlights on multiple sclerosis. Through this journal we are trying to achieve high standards in publication as well as to maintain the same standards and quality like the other international journals on neurological diseases and multiple sclerosis.
Last date updated on June, 2014